查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371958

2030 年數位錠劑市場預測：按產品、適應症、疾病、目標領域、用途、最終用戶和地區進行的全球分析

Digital Pills Market Forecasts to 2030 - Global Analysis By Product (Capsule, Tablet and Microchip Delivery Device), Indication, Disease, Target Area, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球數位錠劑電腦市場規模將達到 6 億美元，預計在預測期內年複合成長率為 11.8%，到 2030 年將達到 17 億美元。

數位錠劑是一種結合了藥物管理和電子監控組件的醫療技術。也稱為智慧藥丸和可攝入感測器。旨在提高藥物依從性、追蹤攝取模式和監測生理資料。該錠劑包含一個由安全材料製成的小型可攝入感測器，通常由矽膠、銅和鎂等元素結構。數位錠劑提供藥物依從性、即時監測、客製化治療計劃、臨床試驗和研究。

根據美國成癮中心的數據，2018 年，美國約有 300 萬名 18 歲青少年患有思覺失調症。思覺失調症患病的上升預計將極大地推動數位醫學領域的發展。

提高老年護理意識

養老服務與數位錠劑的結合可以改善老年人的健康和福祉，讓他們安心地度過晚年。透過提供有關老年人用藥依從性和健康結果的公正資料，數位錠劑可能成為醫學研究和臨床試驗的重要組成部分。患有多種慢性病的長者經常給藥多種藥物治療。使用數位錠劑管理複雜的處方方案、發送提醒和監控用藥依從性，降低用藥錯誤的風險。此外，看護者通知、持續監測和老年友善技術正在推動市場擴張。

嚴格法規

法規監督可確保數位錠劑有效實現其預期的醫療目的。法規首要關注的是確保任何醫療產品（包括數位錠劑）可供病人安全使用。嚴格的法規有助於防止引入潛在有害或危險的技術。數位錠劑必須經過徹底的法規審查，以確保其安全性和有效性。這種要求高且複雜的過程正在阻礙市場需求。

活性化研發活動

數位錠劑領域的研發 (R&D) 活動正在迅速增加。背後的原因是該技術有潛力徹底改變藥物管理並改善患者的治療結果。研究人員正在研究更複雜的感測器，可以準確檢測錠劑何時被攝入。客製化、使用者友善介面、無線通訊協定和數位錠劑小型化的研究正在進一步加速市場成長。

患者可接受性和適用性有限

數位錠劑的患者接受度和適用性有限是由於隱私和安全問題、新穎性和不熟悉性、對技術故障或失敗的恐懼以及有限的可用性和承受能力。患者接受數位藥丸也存在心理障礙。此外，並非所有患者或醫療狀況都可以從數位藥丸中受益。所有這些要素都在抑制市場需求。

COVID-19 的影響

新冠大流行對數位藥丸市場既有正面的影響，也有負面的影響。這場流行病擾亂了全球供應鏈，影響了數位藥丸及其零件的生產和分銷。此外，在封鎖期間，獲得醫療保健服務（包括數位醫療技術）僅限於某些人群。然而，由於對遠端監控、慢性病管理的重視以及遠端醫療的日益採用，該市場正在呈現獲利成長。

思覺失調症患者的後續攝取量預計在預測期內是最大的

思覺失調症患者追蹤攝取量預計將出現良好成長。一些思覺失調症患者面臨著與其病情相關的恥辱。數位錠劑提供了一種不引人注目的方式來監測藥物依從性，無需直接觀察，有助於保護病患的自主權和隱私。它還提供個體化的治療計劃並追蹤一段時間內的藥物依從模式。早期療育和降低復發風險正在推動這一領域的需求。

預計醫院領域在預測期內複合年複合成長率最高。

由於對微創手術治療的需求不斷成長、藥物依從性下降以及全球住院和手術數量不斷增加，預計醫院領域在預測期內將出現最高的年複合成長率。整體而言，發炎性腸道疾病(IBD) 患者的激增促使醫院採用數位錠劑作為診斷程序中的寶貴工具。智慧藥丸是非侵入性的，能夠進行早期檢測和診斷，這推動了該領域的需求。

比最大的地區

由於醫療保健意識的提高、技術的進步以及慢性病負擔的增加，預計亞太地區將在預測期內佔據最大的市場佔有率。亞太地區許多國家正在增加醫療保健支出，以改善醫療保健基礎設施、可近性和品質。世界各國政府正在實施政策和舉措，以加速數位醫療技術的採用。此外，人口高齡化的加劇、臨床研究和醫療保健支出的增加正在推動該地區的市場成長。

複合年複合成長率最高的地區：

由於其強大的技術基礎設施和高齡化，預計北美在預測期內將呈現最高的年複合成長率。北美在醫療保健研究和創新方面處於世界領先地位。該地區擁有眾多正在推動數位健康進步的製藥公司、技術公司和研究機構。心臟病、糖尿病和高血壓等慢性病在北美很常見。定期的合作和夥伴關係以及持續的監控技術正在推動該地區的市場需求。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球數位藥丸市場：按產品

  • 膠囊
  • 藥片
  • 微晶片輸送裝置

第6章 全球數位藥丸市場：依跡象分類

  • 追蹤思覺失調症患者的攝取狀況
  • 追蹤雙極性情感障礙患者的攝取量
  • 重度憂鬱症（MDD）

第7章 全球數位藥丸市場：依疾病分類

  • 癌症
  • 糖尿病
  • 循環系統疾病
  • 感染疾病
  • 精神障礙
  • 其他疾病

第8章 全球數位藥丸市場：按目標地區

  • 食道
  • 小腸
  • 冒號
  • 胃

第9章 全球數位藥丸市場：按應用

  • 膠囊內視鏡
  • 靶向藥物輸送
  • 生命徵象監測

第10章 全球數位藥丸市場：依最終用戶分類

  • 醫院
  • 診斷中心
  • 家庭護理設置
  • 其他最終用戶

第11章全球數位藥丸市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章公司簡介

  • Abbott Laboratories
  • Proteus Digital Health Inc.
  • Pure Tech
  • Medtronic
  • 2morrow Inc.
  • Gentag Inc.
  • AnX Robotica Corporation
  • CapsoVision Inc.
  • Teladoc Health Inc.
  • Microchips Biotech Inc.
  • Omada Health Inc
  • Otsuka Holdings Co Limited
  • Livongo Health
  • Novartis AG
  • Leaf Healthcare Inc
  • Perficient Inc
  • AliveCor Inc
  • WellDoc Inc
  • Mocacare
  • iRhythm Technologies Inc
Product Code: SMRC24015

According to Stratistics MRC, the Global Digital Pills Market is accounted for $0.6 billion in 2023 and is expected to reach $1.7 billion by 2030 growing at a CAGR of 11.8% during the forecast period. Digital pills are a type of medical technology that combines medication with electronic monitoring components. They are also known as smart pills or ingestible sensors. They are designed to improve medication adherence, track ingestion patterns, and monitor physiological data. It contains a tiny ingestible sensor made of safe materials, typically composed of elements like silicon, copper, and magnesium. Digital pills provide medication adherence, real-time monitoring, customized treatment plans, clinical trials and research.

According to the American Addiction Center, in the U.S., around of 3 million people aged 18 suffered from Schizophrenia in 2018. The rising prevalence of Schizophrenia is expected to provide a significant boost to the digital pills sector.

Market Dynamics:

Driver:

Rising awareness of geriatric care

The combination of geriatric care with the use of digital pills improves elderly people's health and well-being, enabling them to age in place with assurance and support. By offering unbiased data on medication adherence and health effects in senior people, digital pills can be a key component of geriatric research and clinical trials. A range of drugs are frequently administered to older people who have several chronic diseases. The risk of medication mistakes can be decreased by using digital pills to manage complicated prescription regimens by sending out reminders and monitoring adherence. Additionally, its notifications to care givers, ongoing surveillance, and age-friendly technology are boosting the market's expansion.

Restraint:

Strict regulations

Regulatory oversight ensures that digital pills are effective in achieving their intended medical purposes. The primary concern of regulatory bodies is to ensure that any medical product, including digital pills, is safe for patients to use. Rigorous regulations help prevent the introduction of potentially harmful or risky technologies. Digital pills need to undergo thorough regulatory scrutiny to provide assurance of their safety and effectiveness. This strict and complex process hampers the market demand.

Opportunity:

Mounting R&D activities

There has been a surge in research and development (R&D) activities in the field of digital pills. This is driven by the potential of this technology to revolutionize medication management and improve patient outcomes. Researchers are working on developing more sophisticated sensors that can accurately detect when a pill is ingested. The research trails for customizations, user friendly interfaces, Wireless Communication Protocols and Miniaturization of digital pills are further accelerating the market growth.

Threat:

Limited patient acceptance & applicability

Limited patient acceptance and applicability for digital pills can be attributed by concerns about privacy and security, novelty and unfamiliarity, fear of technology malfunctions or failures, limited accessibility and affordability and so on. Also, patients may experience psychological barriers for accepting digital pills. In addition, not all patients or medical conditions may benefit from or be suitable for digital pills. All these factors are impeding the market demand.

COVID-19 Impact

The covid pandemic had both positive and negative impacts on the digital pills market. The pandemic led to disruptions in global supply chains, which have affected the production and distribution of digital pills and their components. In addition, access to healthcare services including digital health technologies has been limited for certain populations during lockdowns. But, due to increased emphasis on remote monitoring, focus on chronic disease management and telemedicine adoption the market has witnessed beneficial growth.

The tracking ingestion in schizophrenia patients segment is expected to be the largest during the forecast period

The tracking ingestion in schizophrenia patients segment is estimated to have a lucrative growth. Some individuals with schizophrenia may face stigma related to their condition. Digital pills provide a discreet way to monitor adherence without the need for direct observation, which can help preserve patient autonomy and privacy. Also, it provides personalized treatment plans and tracks adherence patterns over time. Its early intervention and reducing relapse risk is fuelling the segment demand.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rising demand for minimally invasive surgical treatments, poor medication adherence, and an increase in hospitalisations and surgical operations worldwide. Overall, the surge in inflammatory bowel disease (IBD) cases has prompted hospitals to embrace digital pills as a valuable tool in diagnostic procedures. The non-invasive nature of smart pills, coupled with their ability to enhance early detection & diagnosis is boosting the segment demand.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing healthcare awareness, technological advancements, and a rising burden of chronic diseases. Many countries in the Asia Pacific region have been increasing their healthcare spending to improve healthcare infrastructure, accessibility, and quality. Governments in various countries have been implementing policies and initiatives to promote the adoption of digital health technologies. Further, the growing aging population, clinical research & trials and rising healthcare expenditure are driving the market growth in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to its strong technological infrastructure and aging population. North America is a global leader in healthcare research and innovation. The region is home to numerous pharmaceutical companies, technology firms, and research institutions that drive advancements in digital health. Chronic diseases like heart disease, diabetes, and hypertension are prevalent in North America. The region's regular collaborations and partnerships along with continuous monitoring technologies is fuelling the market demand.

Key players in the market:

Some of the key players profiled in the Digital Pills Market include: Abbott Laboratories, Proteus Digital Health Inc., Pure Tech, Medtronic, 2morrow Inc., Gentag Inc., AnX Robotica Corporation, CapsoVision Inc., Teladoc Health Inc., Microchips Biotech Inc., Omada Health Inc, Otsuka Holdings Co Limited, Livongo Health, Novartis AG, Leaf Healthcare Inc, Perficient Inc, AliveCor Inc, WellDoc Inc, Mocacare and iRhythm Technologies Inc.

Key Developments:

In April 2023, Medtronic has announced the launch of MRI Care Pathway, a new system that can streamline the process of completing MRI scans for patients with Medtronic MRI compatible cardiac devices.

In February 2023, AnX Robotica Corp. (US) launched the NaviCam Small Bowel System in the US. The NaviCam SB System utilizes aspherical lens technology to reduce distortion and enhance the field of vision, a critical component in the diagnosis of small bowel disease.

Products Covered:

  • Capsule
  • Tablet
  • Microchip Delivery Device

Indications Covered:

  • Tracking Ingestion in Schizophrenia Patients
  • Tracking Ingestion in Biopolar Patients
  • Major Depressive Disorder (MDD)

Diseases Covered:

  • Cancer
  • Diabetes
  • Cardiovascular Disease
  • Infectious Diseases
  • Mental Disorders
  • Other Diseases

Target Areas Covered:

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Applications Covered:

  • Capsule Endoscopy
  • Targeted Drug Delivery
  • Vital Sign Monitoring

End Users Covered:

  • Hospitals
  • Diagnostic Centers
  • Home Care Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Pills Market, By Product

  • 5.1 Introduction
  • 5.2 Capsule
  • 5.3 Tablet
  • 5.4 Microchip Delivery Device

6 Global Digital Pills Market, By Indication

  • 6.1 Introduction
  • 6.2 Tracking Ingestion in Schizophrenia Patients
  • 6.3 Tracking Ingestion in Biopolar Patients
  • 6.4 Major Depressive Disorder (MDD)

7 Global Digital Pills Market, By Disease

  • 7.1 Introduction
  • 7.2 Cancer
  • 7.3 Diabetes
  • 7.4 Cardiovascular Disease
  • 7.5 Infectious Diseases
  • 7.6 Mental Disorders
  • 7.7 Other Diseases

8 Global Digital Pills Market, By Target Area

  • 8.1 Introduction
  • 8.2 Esophagus
  • 8.3 Small Intestine
  • 8.4 Large Intestine
  • 8.5 Stomach

9 Global Digital Pills Market, By Application

  • 9.1 Introduction
  • 9.2 Capsule Endoscopy
  • 9.3 Targeted Drug Delivery
  • 9.4 Vital Sign Monitoring

10 Global Digital Pills Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Diagnostic Centers
  • 10.4 Home Care Settings
  • 10.5 Other End Users

11 Global Digital Pills Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Abbott Laboratories
  • 13.2 Proteus Digital Health Inc.
  • 13.3 Pure Tech
  • 13.4 Medtronic
  • 13.5 2morrow Inc.
  • 13.6 Gentag Inc.
  • 13.7 AnX Robotica Corporation
  • 13.8 CapsoVision Inc.
  • 13.9 Teladoc Health Inc.
  • 13.10 Microchips Biotech Inc.
  • 13.11 Omada Health Inc
  • 13.12 Otsuka Holdings Co Limited
  • 13.13 Livongo Health
  • 13.14 Novartis AG
  • 13.15 Leaf Healthcare Inc
  • 13.16 Perficient Inc
  • 13.17 AliveCor Inc
  • 13.18 WellDoc Inc
  • 13.19 Mocacare
  • 13.20 iRhythm Technologies Inc

List of Tables

  • Table 1 Global Digital Pills Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Digital Pills Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Digital Pills Market Outlook, By Capsule (2021-2030) ($MN)
  • Table 4 Global Digital Pills Market Outlook, By Tablet (2021-2030) ($MN)
  • Table 5 Global Digital Pills Market Outlook, By Microchip Delivery Device (2021-2030) ($MN)
  • Table 6 Global Digital Pills Market Outlook, By Indication (2021-2030) ($MN)
  • Table 7 Global Digital Pills Market Outlook, By Tracking Ingestion in Schizophrenia Patients (2021-2030) ($MN)
  • Table 8 Global Digital Pills Market Outlook, By Tracking Ingestion in Biopolar Patients (2021-2030) ($MN)
  • Table 9 Global Digital Pills Market Outlook, By Major Depressive Disorder (MDD) (2021-2030) ($MN)
  • Table 10 Global Digital Pills Market Outlook, By Disease (2021-2030) ($MN)
  • Table 11 Global Digital Pills Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 12 Global Digital Pills Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 13 Global Digital Pills Market Outlook, By Cardiovascular Disease (2021-2030) ($MN)
  • Table 14 Global Digital Pills Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 15 Global Digital Pills Market Outlook, By Mental Disorders (2021-2030) ($MN)
  • Table 16 Global Digital Pills Market Outlook, By Other Diseases (2021-2030) ($MN)
  • Table 17 Global Digital Pills Market Outlook, By Target Area (2021-2030) ($MN)
  • Table 18 Global Digital Pills Market Outlook, By Esophagus (2021-2030) ($MN)
  • Table 19 Global Digital Pills Market Outlook, By Small Intestine (2021-2030) ($MN)
  • Table 20 Global Digital Pills Market Outlook, By Large Intestine (2021-2030) ($MN)
  • Table 21 Global Digital Pills Market Outlook, By Stomach (2021-2030) ($MN)
  • Table 22 Global Digital Pills Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Digital Pills Market Outlook, By Capsule Endoscopy (2021-2030) ($MN)
  • Table 24 Global Digital Pills Market Outlook, By Targeted Drug Delivery (2021-2030) ($MN)
  • Table 25 Global Digital Pills Market Outlook, By Vital Sign Monitoring (2021-2030) ($MN)
  • Table 26 Global Digital Pills Market Outlook, By End User (2021-2030) ($MN)
  • Table 27 Global Digital Pills Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Global Digital Pills Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 29 Global Digital Pills Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 30 Global Digital Pills Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.